Rana McKay: First randomized SABR study in RCC for NCI

Rana McKay shared a post on X:

“Critically important study testing role of SABR to renal primary in mRCC.

First randomized SABR study in RCC for NCI! We need your support!”

Source: Rana McKay/X

Rana McKay is a board-certified medical oncologist and specializes in urogenital cancers, offering treatment for bladder, kidney, prostate, and testicular cancer patients. Leading a multi-disciplinary prostate cancer clinic at UC San Diego, she ensures comprehensive care through collaboration with urologists and radiation oncologists.

As an associate professor, Dr. McKay mentors students and conducts research on clinical trials and novel biomarkers for genitourinary malignancies. Dr. McKay is a member of the American Society of Clinical Oncology and the American Association for Cancer Research.